intrinsic

Hospitals

Josh SandbergDecember 22, 2016
1,366

Intrinsic Therapeutics announces the Filing of PMA Application for its Barricaid® Anular Closure Device for Lumbar Discectomy Patients.

BOSTON, Dec. 21, 2016 /PRNewswire/ — Intrinsic Therapeutics, Inc. announced today that the filing of its Pre-Market Approval (PMA) application with the Food…
Read More »
Josh SandbergFebruary 18, 2011
1,354

Intrinsic Enrolls First Patient in Barricaid® Trial

WOBURN, Mass., Feb. 17, 2011 /PRNewswire/ — Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that…
Read More »